2020. november 23., hétfő 12:00 |
Fresenius Kabi and ASPEN partner for an expert interview series on omega-3 fatty acid containing parenteral nutrition |
|
Bad Homburg, Germany, 23 November, 2020 (APA/OTS) - Evidence indicates that omega-3 (w-3) fatty acid containing parenteral nutrition (PN) improves clinical outcomes compared with standard PN in adult patients,(1) underlining its role in today's hospitals and clinics. To support continuous health care professional (HCP) education on omega-3 fatty acids in clinical nutrition, the American Society for Parenteral and Enteral Nutrition (ASPEN) has partnered with Fresenius Kabi to create the Omega-3 Fatty Acids Key Expert Interview Series, which includes five interviews addressing important aspects of omega-3 fatty acids impacting patient care. |
The interview series features the following experts and topics:
Mette M. Berger, MD, PhD (Role and Mechanism of Action of omega-3
Fatty Acids); Robert G. Martindale, MD, PhD (Guideline
Recommendations and Use in Surgical Patients); Martin D. Rosenthal,
MD (Use in the Chronic Critical Care Patient); Lorenzo Pradelli, MD
(Cost Effectiveness of omega-3 Fatty Acids); and Manpreet S Mundi,
MD (Omega-3 Fatty Acids in Long-term Intestinal Failure Patients).
The esteemed experts were interviewed by Jay Mirtallo, MS, RPh,
BCNSP, FASPEN, FASHP, who is well published in the area of
intravenous lipids.
This short video interview series is available at this link.
https://www.youtube.com/playlist?list=PL-rWCuTTwTKzOuXWmTmUUwUXoS0KQOurk
Clinicians can also watch previous ASPEN webinars on omega-3 fatty
acids:
- Expert Consensus on Omega-3 Fatty Acids in Parenteral Nutrition:
Continuum of Care - from Hospital to Home Care
- Expert Consensus on Omega-3 Fatty Acids in Parenteral Nutrition:
Focus on Critical Care and Major Surgery
The digital interviews and past webinars are supported by global
clinical nutrition leader, Fresenius Kabi. The supplement of the
2020 Journal of Parenteral and Enteral Nutrition Lipids in
Parenteral Nutrition: Translating Guidelines into Clinical Practice
was also developed on the topic of omega-3 fatty acids with support
from Fresenius Kabi.
# # #
References (1). Pradelli L, Mayer K, Klek S et al. ?-3 Fatty-Acid Enriched
Parenteral Nutrition in Hospitalized Patients: Systematic Review
With Meta-Analysis and Trial Sequential Analysis. JPEN J Parenter
Enteral Nutr. 2019.
About Fresenius Kabi
Fresenius Kabi is a global healthcare company that specializes in
lifesaving medicines and technologies for infusion, transfusion and
clinical nutrition. The company's products and services are used to
help care for critically and chronically ill patients. Fresenius
Kabi's product portfolio comprises a comprehensive range of I.V.
generic drugs, infusion therapies and clinical nutrition products as
well as the medical devices for administering these products. Within
transfusion technologies, Fresenius Kabi offers products for
collection and processing of blood components and for therapeutic
treatment of patient blood by apheresis systems. In the field of
biosimilars, Fresenius Kabi develops products with a focus on
oncology and autoimmune diseases.
With its corporate philosophy of "caring for life", the company is
committed to putting essential medicines and technologies in the
hands of people who help patients and finding the best answers to
the challenges they face.
For more information, please visit www.fresenius-kabi.com.
About ASPEN
The American Society for Parenteral and Enteral Nutrition (ASPEN)
is dedicated to improving patient care by advancing the science and
practice of nutrition support therapy and metabolism. Founded in
1976, ASPEN is an interdisciplinary organization whose members are
involved in the provision of clinical nutrition therapies, including
parenteral and enteral nutrition. With more than 6,500 members from
around the world, ASPEN is a community of dietitians, nurses, nurse
practitioners, pharmacists, physicians, scientists, students and
other health professionals from every facet of nutrition support
clinical practice, research and education. For more information
about ASPEN, please visit www.nutritioncare.org.
For press inquiries, please contact: Nina Espiritu Edelman GmbH Am Sandtorkai 50, 20457 Hamburg, Germany T: +49 (0)69 509546339 nina.espiritu@edelman.com
-------------------------------------------------------------------
Az OTS internetes oldalán található hírek, közlemények, fotók
a forrásmegjelöléssel (OTS) szabadon és korlátozás nélkül
felhasználhatók. Továbbközlés esetén a közzétevő köteles az átvett
anyagot tartalmának torzítása nélkül, félreérthetőséget,
rosszindulatú következtetéseket kizáró, az eredeti
szövegkörnyezetnek megfelelő módon feldolgozni és megjelentetni.
Az OTS hírek nem képezik az MTI hírkiadás részét, az MTI
által szó szerint továbbított tartalomért minden esetben a beadó a
felelős. © Copyright MTI nonprofit Zrt.
Az OTS szolgáltatással kapcsolatban további információt a
(06-1) 441-9050 telefonszámon vagy a ots@mti.hu elektronikus
levelező címen kaphat.
|
|
|
|
|
|
|
Forrás: OTS Üzleti Sajtószolgálat
MTI © Minden jog fenntartva.
|